The H1 21 results came in above consensus.
Q2 and H1 are the best released since 2008, on the back of sky-rocketing prices.
The performance is seen across the board with all geographies benefiting from very high prices.
The balance sheet is further deleveraged, enabling an extension of the share buy-back programme to US$2.2bn.
We will upgrade again our forecasts and target price, even if the visibility for FY22 is still very low.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A rather fantastic H1 21
The H1 21 results came in above consensus.
Q2 and H1 are the best released since 2008, on the back of sky-rocketing prices.
The performance is seen across the board with all geographies benefiting from very high prices.
The balance sheet is further deleveraged, enabling an extension of the share buy-back programme to US$2.2bn.
We will upgrade again our forecasts and target price, even if the visibility for FY22 is still very low.